DRUG · Mapped RxNorm record
Natalizumab Injection [Tysabri]
Normalized identity: natalizumab Injection [Tysabri]View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Real World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
NCT04580381
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedReal World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Multiple Sclerosis, Relapsing-Remittingunresolved
Interventions
Natalizumab Injection [Tysabri]DRUG · verified · RxNorm: natalizumab Injection [Tysabri]
Sponsors & collaborators
University Hospital, Caenlead sponsor
Biogencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04580381 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.